Clindamycin

Chemical formula: C₁₈H₃₃ClN₂O₅S  Molecular mass: 424.98 g/mol  PubChem compound: 446598

Active ingredient description

Clindamycin is a lincosamide antibiotic with a primarily bacteriostatic action against Gram-positive aerobes and a wide range of anaerobic bacteria. Lincosamides such as clindamycin bind to the 50S subunit of the bacterial ribosome and inhibit the early stages of protein synthesis.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
D10AF01 Clindamycin D Dermatologicals → D10 Anti-acne preparations → D10A Anti-acne preparations for topical use → D10AF Antiinfectives for treatment of acne
Discover more medicines within D10AF01
G01AA10 Clindamycin G Genito urinary system and sex hormones → G01 Gynecological antiinfectives and antiseptics → G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS → G01AA Antibiotics
Discover more medicines within G01AA10
J01FF01 Clindamycin J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FF Lincosamides
Discover more medicines within J01FF01

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
CLINDAMYCIN Capsule Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
CLINDAMYCIN Solution for Injection or Infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
DALACIN T Topical solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
DALACIN CREAM Vaginal Cream Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 18323-44-9
CAS Substance: 21462-39-5
CAS Substance: 24729-96-2
DrugBank Drug: DB01190
KEGG Drug: D00277
PubChem Compound: 446598
RxNorm Ingredient: 2582
SNOMED-CT Concept: 372786004
Clindamycin (substance)
UNII Identifier: 3U02EL437C
CLINDAMYCIN

Medicines

Clindamycin is an active ingredient of these brands:

United States (US)

Australia (AU)

Austria (AT)

Brazil (BR)

Canada (CA)

Croatia (HR)

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

Finland (FI)

  • DALACIN as CLINDAMYCIN PHOSPHATE
  • (combination) ACNATAC as CLINDAMYCIN PHOSPHATE
  • (combination) CLINDOXYL as CLINDAMYCIN PHOSPHATE

France (FR)

  • DALACINE as CLINDAMYCIN HYDROCHLORIDE MONOHYDRATE
  • ZINDACLINE as CLINDAMYCIN PHOSPHATE
  • (combination) ZANEA as CLINDAMYCIN PHOSPHATE

Germany (DE)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

Italy (IT)

Japan (JP)

Lithuania (LT)

Malta (MT)

Mexico (MX)

Netherlands (NL)

New Zealand (NZ)

Nigeria (NG)

Poland (PL)

Romania (RO)

  • DALACIN-C
  • OVYX as CLINDAMYCIN PHOSPHATE
  • (combination) ACNATAC as CLINDAMYCIN PHOSPHATE
  • (combination) DUAC as CLINDAMYCIN PHOSPHATE

Singapore (SG)

South Africa (ZA)

Spain (ES)

Tunisia (TN)

  • DALACINE as CLINDAMYCIN HYDROCHLORIDE MONOHYDRATE

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈